At the time of writing, Biohaven Ltd [BHVN] stock is trading at $10.48, down -0.57%. An important factor to consider is whether the stock is rising or falling in short-term value. The BHVN shares have gain 18.69% over the last week, with a monthly amount glided 26.88%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on December 03, 2025, when H.C. Wainwright downgraded its rating to a Neutral but kept the price target unchanged to $11 for it. Previously, UBS downgraded its rating to Neutral on November 26, 2025, and kept the price target unchanged to $11. On November 06, 2025, downgrade downgraded it’s rating to Mkt Perform but maintained its price target of $9 on the stock. BofA Securities downgraded its rating to a Neutral but stick to its price target of $10 on November 05, 2025. Citigroup initiated its recommendation with a Buy and recommended $28 as its price target on September 17, 2025. Raymond James started tracking with a Strong Buy rating for this stock on September 03, 2025, and assigned it a price target of $75. In a note dated May 19, 2025, RBC Capital Mkts downgraded an Sector Perform rating on this stock but restated the target price of $21.
For the past year, the stock price of Biohaven Ltd fluctuated between $7.48 and $45.87. Currently, Wall Street analysts expect the stock to reach $22.5 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $10.48 at the most recent close of the market. An investor can expect a potential return of 114.69% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.91, Equity is -3.9 and Total Capital is -2.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -17.99.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.06 points at the first support level, and at 9.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.76, and for the 2nd resistance point, it is at 11.05.
Ratios To Look Out For
It is important to note that Biohaven Ltd [NYSE:BHVN] has a current ratio of 2.86. On the other hand, the Quick Ratio is 2.86, and the Cash Ratio is 1.64.
Transactions by insiders
Recent insider trading involved Clark George C., VP, Chief Accounting Officer, that happened on Nov 17 ’25 when 17000.0 shares were purchased. Director, Bailey Gregory completed a deal on Nov 13 ’25 to buy 0.4 million shares. Meanwhile, Director CHILDS JOHN W bought 3.33 million shares on Nov 13 ’25.
